EN
HI
Summary
As of 14 Nov, 2026, Laurus Labs stock price is ₹2424. During the trading session, the stock has moved between an intraday low of ₹2335.00 and an intraday high of ₹2545.20. Over the last 52 weeks, Laurus Labs has traded between ₹917.95 and ₹2545.20.
The stock has recorded a trading volume of 6,89,134 shares,. Its Average Traded Price (ATP) is ₹2421.83, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2424.00.
Laurus Labs has an upper circuit limit of ₹2640.00 and a lower circuit limit of ₹2160.00. The total value traded stands at ₹166.90 CR, and the delivery percentage for the day is 55.4%.
The stock is currently traded with a market lot size of 1. Laurus Labs also offers a dividend yield of 0.08%.
Laurus Labs Share Price Chart
Laurus Labs Share Key Metrics
Volume
6.89 L
Market Cap
130971.68 CR
LTQ@LTP
1@2424.00
ATP
2421.83
Var Margin
16.4 %
Circuit Range
2160-2640
Delivery %
55.4 %
Value
166.90 CR
ASM/GSM
No
Market Lot
1
Laurus Labs Fundamentals
P/E Ratio
96.58
P/B Ratio
21.35
Div. Yield
0.08
Sector P/E
41.35
Sector P/B
3.85
Sec. Div. Yield
0.53
Laurus Labs Resistance and Support
Pivot 2404.73
Resistance
First Resistance
2429.46
Second Resistance
2458.93
Third Resistance
2483.66
Support
First Support
2375.26
Second Support
2350.53
Third Support
2321.06
Laurus Labs Futures & Options
Laurus Labs Option Chain
View Price, OI, Greeks & More...
23NOV26
2444.00
35.90 (1.49%)
29DEC26
2459.50
38.40 (1.59%)
25JAN27
2463.60
24.70 (1.01%)
LAURUSLABS|23NOV26 CE 2420.00
63.85
20.15 (46.11%)
LAURUSLABS|23NOV26 PE 2440.00
49
-18.9 (-27.84%)
Laurus Labs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 2400 | 2424 | 1.00% | 2446.9 | 2394 |
| Thu Nov 12 2026 | 2427 | 2400 | -1.19% | 2434.19 | 2380 |
| Wed Nov 11 2026 | 2480 | 2429 | -1.02% | 2488 | 2416.89 |
Laurus Labs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-29 | Quarterly Results & Interim Dividend |
| 2026-07-24 | Quarterly Results |
| 2026-04-30 | Audited Results & Interim Dividend |
| 2026-01-23 | Quarterly Results |
| 2025-10-23 | Quarterly Results & Interim Dividend |
| 2025-07-25 | Quarterly Results |
| 2025-04-24 | Audited Results & Interim Dividend |
| 2025-01-24 | Quarterly Results |
| 2024-10-24 | Quarterly Results & Interim Dividend |
| 2024-07-25 | Quarterly Results |
Laurus Labs News
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Laurus Labs reported robust Q2 FY27 results with net profit jumping 126% YoY to Rs.441 crore and revenue rising 33% YoY to Rs.2,206 crore. The company also announced the acquisitions of a 60% stake in Galenvs Sciences and a 52% stake in SI & C Resins to bolster CDMO offerings.
Oct 29 2026 15:36:30
Laurus Labs Ltd - 540222 - Corporate Action-Board approves Dividend
Laurus Labs has declared an interim dividend of ₹1.00 per equity share for the financial year 2026-27, representing a 50% payout on the face value of ₹2. The record date to determine shareholder eligibility is fixed as November 6, 2026. The dividend payments will be processed on or after November 19, 2026.
Oct 29 2026 15:13:11
Read More
Laurus Labs Management
| Name | Position |
|---|---|
| G Venkateswar Reddy | Company Secretary & Compliance Officer |
| Ravindranath Kancherla | Chairman |
Laurus Labs Similar Stocks
Sun Pharmaceutical Industries Ltd.
2068.00
183.00 (9.71%)
Divi's Laboratories Ltd.
11837.00
352.00 (3.06%)
Torrent Pharmaceuticals Ltd.
4682.80
-44.40 (0.94%)
Lenskart Solutions Ltd.
810.60
83.15 (11.43%)
Apollo Hospitals Enterprise Ltd.
8952.50
437.50 (5.14%)
Zydus Lifesciences Ltd.
1250.00
44.00 (3.65%)
Dr. Reddy's Laboratories Ltd.
1510.00
123.40 (8.90%)
Cipla Ltd.
1350.00
-58.30 (4.14%)
Mankind Pharma Ltd.
2661.90
23.30 (0.88%)
Aurobindo Pharma Ltd.
1777.10
-30.10 (1.67%)
Laurus Labs FAQs
The Buying Price of Laurus Labs share is 2424 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Laurus Labs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Laurus Labs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Laurus Labs shares is 96.58. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Laurus Labs shares is 21.35. Useful to assess the stock's value relative to its book value.
To assess Laurus Labs’s valuation compare Sector P/E, P/B which are 41.35 & 3.85 with sector averages, along with growth rates and financial metrics.
The Market Cap of Laurus Labs is 130971.68 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Laurus Labs share price is 2545.20 & 917.95. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Laurus Labs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in LAURUSLABS
Or Download Choice FinX App
Invest in LAURUSLABS
